»áÕ¹Ãû³Æ | 2012Äêϸ°ûÉúÎïѧ²¡¶¾½øÈë¸´ÖÆÓë·¢²¡ÔÀí»áÒ飨SBVE£© |
²¼Õ¹Ê±¼ä | 2012Äê3ÔÂ25ÈÕ |
Õ¹ÀÀʱ¼ä | 2012Äê3ÔÂ26ÈÕ—2012Äê3ÔÂ31ÈÕ |
³·Õ¹Ê±¼ä | 2012Äê4ÔÂ1ÈÕ |
ËùÔÚµØÖ· |
¼ÓÄôó »Ý˹ÀÕ |
»áÕ¹³¡¹Ý | »Ý˹ÀÕ»áÕ¹ÖÐÐÄ |
²Î»á×¢²á·Ñ | ¿ÉÒÔ. »áÔ±/·Ç»áÔ±795ÃÀÔª ·þÎñ·Ñ300ÈËÃñ±Ò/ÈË |
´úËÍǩ֤ | ¿ÉÒÔ. ·þÎñ·Ñ500ÈËÃñ±Ò/ÈË |
´ú¶©»úƱ | ¿ÉÒÔ. ÇëÓë¿Í·þÈËÔ±ÁªÏµ |
´ú¶¨Õ¹Î» |
²»¿ÉÒÔ |
´ú¶¨¾Æµê |
¿ÉÒÔ. ·þÎñ·ÑΪ×Ü·ÑÓÃ15% |
»áÕ¹ÃèÊö |
This meeting will highlight recent advances in virus infection pathways, and in the cellular responses to viral infection. The meeting features multiple stages of the viral lifecycle analyzed using a broad array of techniques and levels of analysis. A novel feature of this meeting is that it will be held concurrently with the Keystone Symposia meeting on Frontiers in HIV Pathogenesis, Therapy and Eradication and will, therefore, focus on maximizing exchange between the HIV community and the broader community of virologists. An explicit goal is to bring together and promote potential synergies among researchers who might not otherwise interact in more specialized meetings. A classic, almost paradigmatic, example of the power of this cross-talk is the contribution of studies of influenza A virus hemagglutinin to our understanding of the HIV-1 entry process, and the subsequent contribution of both systems to our understanding of type I fusion, type II fusion and the entry processes of non-enveloped viruses. Accordingly, two common sessions will focus on the retroviral entry process and its inhibition, followed by talks featuring a broader survey of viral entry, replication, structural and systems approaches to virology, host immune evasion and therapeutics. ±¾´Î»áÒ齫ͻ³öÔÚ²¡¶¾¸ÐȾ;¾¶µÄ×îнøÕ¹£¬²¢ÔÚ²¡¶¾¸ÐȾµÄϸ°û·´Ó¦¡£»áÒéÉèÓжà¸ö²¡¶¾µÄÉúÃüÖÜÆÚ·ÖÎö£¬Ê¹Óõļ¼ÊõºÍ²ã´Î·ÖÎöºÆÈçÑ̺£½×¶Î¡£±¾´Î»áÒéµÄÒ»¸öÐÂÌØµãÊÇ£¬Õ⽫ÊÇÓë°¬×̲¡·¢²¡»úÀíµÄÇ°ÑØÌÝÐÎÑÐÌÖ»á»áÒéͬʱ¾ÙÐУ¬ÖÎÁƺͲù³ý£¬Òò´Ë£¬Öصã·ÅÔÚ×î´óÏ޶ȵØÌá¸ß°¬×̲¡¶¾µÄÉç»áºÍ²¡¶¾Ñ§¼Ò¸ü¹ã·ºµÄÉçÇøÖ®¼äµÄ½»Á÷¡£Ò»¸öÃ÷È·µÄÄ¿±êÊǻ㼯ºÍ´Ù½øÑо¿ÈËÔ±Ö®¼äµÄDZÔÚÐͬЧӦ£¬·ñÔò¿ÉÄÜÎÞ·¨»¥¶¯£¬¸üרÃŵĻáÒé¡£¾µä£¬¼¸ºõµä·¶£¬ÕâÖÖ´®ÈʦÂʵÄÀý×ÓÊÇAÐÍÁ÷¸Ð²¡¶¾ÑªÄýËØµÄÑо¿ÓÐÖúÓÚÎÒÃÇÁ˽âHIV - 1µÄÊäÈë¹ý³Ì£¬ºÍËæºóÁ½¸öϵͳµÄ¹±Ï×£¬ÎÒÃÇÀí½âÀàÐ͵ÄÎÒÈÚºÏIIÐÍÈںϺͷǰüĤ²¡¶¾µÄ½ø³Ì¡£Òò´Ë£¬Á½ÖÖ³£¼ûµÄ»áÒ齫֨µã¶ÔÄæ×ªÂ¼²¡¶¾µÄÊäÈë¹ý³Ì£¬ÆäÒÖÖÆ¾ßÓв¡¶¾½øÈë¸ü¹ã·ºµÄµ÷²é£¬¸´ÖÆ£¬½á¹¹ºÍϵͳ£¬²¡¶¾Ñ§£¬ËÞÖ÷ÃâÒßÌӱܺÍÖÎÁÆ·½·¨µÄ»á̸¡£ |
Õ¹»áÖÜÆÚ |
ÿÄêÒ»½ì¡¡ |
×¢ÒâÊÂÏî |
1.ÒÔÉϱê×¢"¿ÉÒÔ"µÄ·þÎñÏîÄ¿¿Éµ¥¶À°ìÀí. |
ÔÚÏß×Éѯ | |
ÓÑÇéÌáʾ |
»ãÂʼÆËãÒÔ¸¶¿îʱÖйú¹¤ÉÌÒøÐÐÍâ»ãÂô³ö¼ÛΪ׼. |
ÁªÏµ·½Ê½ |
×Éѯµç»°: 8610-66054455 8610-51294800 ÉèËߵ绰: 8610-66054488 |